Literature DB >> 18081619

Brief assessment of cognition in schizophrenia: validation of the Japanese version.

Yasuhiro Kaneda1, Tomiki Sumiyoshi, Richard Keefe, Yasuhito Ishimoto, Shusuke Numata, Tetsuro Ohmori.   

Abstract

This preliminary study was performed to test the reliability and validity of the Brief Assessment of Cognition in Schizophrenia (BACS) as an assessment tool in a Japanese-language version (BACS-J). The subjects for the present study were 30 outpatients with chronic schizophrenia. Each subject gave written informed consent to participate in the research. Cronbach's alpha for the BACS-J was 0.77. The BACS-J composite score was significantly correlated with all primary measures of BACS-J (verbal memory, working memory, motor speed, verbal fluency, attention, and executive function). All BACS-J primary measures and the composite score were significantly correlated between two assessments. The mean score of the Digit Sequencing Task and composite score on the second assessment were significantly larger than those on the first assessment. All BACS-J primary measures except the Symbol Coding Task were significantly correlated with relevant standard neurocognitive tests. Also, the BACS-J composite score was significantly correlated with all standard neurocognitive tests except the Continuous Performance Test. A principal components analysis with varimax rotation resulted in a three-factor solution (executive function and memory; motor speed and general cognitive functions; and working memory). This preliminary study indicates that the BACS-J is a reliable and practical scale to evaluate cognitive function.

Entities:  

Mesh:

Year:  2007        PMID: 18081619     DOI: 10.1111/j.1440-1819.2007.01725.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  62 in total

1.  Impaired musical ability in people with schizophrenia.

Authors:  Sanae Hatada; Ken Sawada; Masanori Akamatsu; Erina Doi; Masayoshi Minese; Motoshi Yamashita; Allen E Thornton; William G Honer; Shimpei Inoue
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

2.  Cognitive impairments in psychotic disorders: common mechanisms and measurement.

Authors:  Deanna M Barch; Julia M Sheffield
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia.

Authors:  Taro Kishi; Yasuhisa Fukuo; Tomo Okochi; Kunihiro Kawashima; Masatsugu Moriwaki; Osamu Furukawa; Kiyoshi Fujita; Giovanna M Musso; Christoph U Correll; John M Kane; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2012-03-28       Impact factor: 3.843

4.  Immunoglobulin genotypes and cognitive functions in schizophrenia.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Paul J Nietert; Reiji Yoshimura; Hikaru Hori
Journal:  Immunogenetics       Date:  2017-09-22       Impact factor: 2.846

5.  Cognitive Remediation Interventions in Autism Spectrum Condition: A Systematic Review.

Authors:  Yasemin Dandil; Katherine Smith; Emma Kinnaird; Cindy Toloza; Kate Tchanturia
Journal:  Front Psychiatry       Date:  2020-07-24       Impact factor: 4.157

6.  Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.

Authors:  Tsutomu Takahashi; Mihoko Nakamura; Daiki Sasabayashi; Yuko Komori; Yuko Higuchi; Yumiko Nishikawa; Shimako Nishiyama; Hiroko Itoh; Yuri Masaoka; Michio Suzuki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-10-25       Impact factor: 5.270

7.  Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia.

Authors:  Yuko Higuchi; Tomiki Sumiyoshi; Takahiro Tateno; Suguru Nakajima; Daiki Sasabayashi; Shimako Nishiyama; Yuko Mizukami; Tsutomu Takahashi; Michio Suzuki
Journal:  J Pers Med       Date:  2021-04-21

8.  Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomes.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Shimako Nishiyama; Yuko Mizukami; Naoyuki Katagiri; Naohisa Tsujino; Takahiro Nemoto; Atsushi Sakuma; Masahiro Katsura; Noriyuki Ohmuro; Naohiro Okada; Mariko Tada; Motomu Suga; Norihide Maikusa; Shinsuke Koike; Atsushi Furuichi; Mikio Kido; Kyo Noguchi; Hidenori Yamasue; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Transl Psychiatry       Date:  2021-07-14       Impact factor: 6.222

9.  Profile of blonanserin for the treatment of schizophrenia.

Authors:  Tomomi Tenjin; Seiya Miyamoto; Yuriko Ninomiya; Rei Kitajima; Shin Ogino; Nobumi Miyake; Noboru Yamaguchi
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-29       Impact factor: 2.570

10.  LORETA current source density for duration mismatch negativity and neuropsychological assessment in early schizophrenia.

Authors:  Tomohiro Miyanishi; Tomiki Sumiyoshi; Yuko Higuchi; Tomonori Seo; Michio Suzuki
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.